Is Vaping Marijuana Safer than Smoking it?

Aug.03.2022
Is Vaping Marijuana Safer than Smoking it?
Electronic cannabis vaporizers offer a safer alternative to smoking, but concerns remain about unregulated products and potential health risks.

Marijuana e-cigarettes are believed to be a safer alternative to smoking. Users can still benefit from all the advantages of cannabinoids and terpenes without inhaling carbon monoxide, particulate matter from plants, or over 100 toxins released during combustion.


However, a few years ago, the outbreak of lung disease (mostly related to the use of illegal THC oil) challenged this sense of safety. Acetate vitamin E, a cheap thickening agent used for diluting oil, was identified as the culprit and quickly removed from products. However, it may still persist in illegal oils and e-cigarettes.


Despite a sharp decline in the incidence of lung disease related to electronic vapor products, or EVALI, since reaching its peak in September 2019, concerns about the safety of marijuana vaporization persist in peer-reviewed scientific reports and mainstream media sources. While numerous articles have been written comparing the pros and cons of vaping electronic cigarettes versus consuming marijuana, it is important to revisit this issue in the post-vitamin E acetate era for comparison.


Why cannabis?


According to reports, the popularity of vaping cannabis is increasing along with the legal availability. However, vaping is rarely the sole method of consuming cannabis, as only 13% exclusively vape it. People often opt to vape cannabis instead of smoking it because it is more convenient, discreet, and efficient. Sometimes, people simply do not want their space to smell like weed.


E-cigarettes are also considered a safer choice because heating the liquid rarely exceeds 400°F, whereas burning flowers can reach close to 500°F, thus reducing the amount of harmful gases and toxins inhaled.


In addition, for those seeking specific and replicable effects, cannabinoids such as tetrahydrocannabinol (THC) or cannabidiol (CBD) and terpenes found in vaping cartridges can provide consistent results.


Furthermore, by adding cannabinoids and terpenes to traditional cultivation methods and strain genetics, optimization can be tailored to specific therapeutic needs or recreational desires. It is important to note, however, that the scientific evidence behind the combinations for therapeutic optimization is still primarily theoretical.


Is vaping safer than smoking cigarettes?


Over the past few years, there has been no controlled and randomized study directly comparing the safety of smoking and using electronic cigarettes using a standard causal inference model.


However, the belief that e-cigarettes do not harm the lungs may be a misconception. A study conducted in 2020 among 2,553 young people found that using e-cigarettes for marijuana at any time increased the risk of developing bronchial symptoms, such as shortness of breath. This result persisted even after adjusting for nicotine e-cigarettes and using marijuana or tobacco.


Last month, it was reported that using an electronic cigarette at least three times can double the risk of wheezing. Wheezing occurs when a person's airways become partially obstructed and they make a short whistling or rattling sound while breathing. However, it is important to note that the potential impact of previous exposure to vitamin E on the lungs cannot be ruled out as we approach the era of vitamin E acetate.


Studies on electronic cigarettes clearly indicate that they are associated with adverse effects on the lungs and airways. Even without nicotine, inflammation in the airways may be caused by the vaping liquid itself, suggesting that some of these effects may also extend to the vaporization of cannabinoids.


The anti-inflammatory properties of tetrahydrocannabinol (THC) and cannabidiol (CBD), particularly when used together, may counteract some of the inflammatory effects of cannabis vaporization. However, respiratory irritation is typically reported with cannabis vaporization, indicating that some level of inflammation may still occur.


When consuming unregulated e-cigarette products, there may be additional health issues that arise. While vitamin E acetate has largely disappeared from vape products, heating it can release destructive gases that contributed to the 2019 EVALI epidemic, which can be produced by other compounds found in unregulated delta-8, CBN, and CBG e-cigarette products. It is crucial to understand the contents of one's e-cigarette shopping cart for safe use.


Is there a difference in the effects between vaping and smoking?


The results of studies comparing smoking and vaping cannabis highlight the challenges researchers face when examining these consumption methods. Differences in usage history, frequency, and natural physiological variances can affect the levels of cannabinoids that enter the body and how long they remain.


In a study, when inhalation amounts were strictly controlled, there was no significant difference in the levels of tetrahydrocannabinol or other cannabinoids collected in the blood using these two methods.


However, in a study on infrequent marijuana users (meaning no use in the past 30 days), vaporizing was found to cause an increase in tetrahydrocannabinol (THC) content in the blood compared to smoking, resulting in greater impairment on various cognitive, visual, and subjective measures.


Similarly, another study investigated how smoking and e-cigarette use affect appetite and metabolism-related hormones after consuming a standard breakfast. While both smoking and vaping marijuana lowered insulin levels, smoking marijuana resulted in a greater decrease in insulin levels 15 minutes after use.


The decrease of insulin can partially explain the low incidence of type II diabetes among regular cannabis users, a disease that originates from excessive release of insulin and ultimately leads to insulin resistance.


Which is better? Smoking or vaping?


The EVALI panic of 2019 tarnished the safety reputation of vape devices in the eyes of the public, media, and research community. Reports of harm caused by cannabis vaporization may lead to "white hat bias" - where people unintentionally distort information to fit societal expectations or personal views of the industry.


In this situation, the historical illegality and ingrained societal beliefs about the harmful effects of marijuana may lead to the idea that consuming marijuana, even if no more harmful than smoking tobacco, is equally harmful.


Some individuals may report that although there is a lack of evidence indicating an increase in the harm of electronic cigarettes, their subjective experiences align with these beliefs. However, although most devices no longer contain publicly harmful additives that caused hospitalization and death during the EVALI outbreak, illegal and unapproved devices and e-cigarette liquids continue to circulate.


Studies comparing the long-term safety and health effects of smoking and electronic cigarettes have typically captured the extended usage of these unregulated products, which are more easily accessible. However, it remains difficult to draw conclusions regarding the long-term safety of electronic cigarettes based on existing devices and e-liquids.


There is no significant difference in the impact of acute smoking and e-cigarette use on the concentration of cannabinoids in the body. However, the differences in puff patterns between smoking a bowl and using an e-cigarette may have varying effects on the brain and body. Ultimately, as with most cannabis products, understanding its contents, the reputation of its source, and regulating intake are the key factors for safe and effective use.


This article is compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not reflect the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's content. The compilation of this article is only for industry communication and research purposes.


Due to limitations in the translation process, the translated article may not fully reflect the original text. Therefore, please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and international matters and positions.


The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
NEXTECH launched its NEXE Pro circumferential-heating tobacco stick globally at InterTabac 2026, as the company expands from product innovation into broader heated tobacco solutions. Amid intensifying competition across global HTP markets, NEXTECH is strengthening its R&D, manufacturing and pre-launch support capabilities to serve different types of business customers.
Industry Insight
Sep.15
Swedish-Founded Nicotine Pouch Retailer GotPouches Shifts to U.S.-Based Operations, Reaching Over 25 States
Swedish-Founded Nicotine Pouch Retailer GotPouches Shifts to U.S.-Based Operations, Reaching Over 25 States
Swedish-founded online nicotine pouch retailer GotPouches has completed the localization of its U.S. operations under UpNorth Retail LLC, with corporate operations in Franklin, Tennessee, domestic fulfillment from Nashville and U.S.-based customer support. The company says its catalog covers more than 20 nicotine pouch brands and it currently serves customers in more than 25 U.S. states.
Sep.18
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
Yinghe-Controlled Vape Maker SKE Ordered to Post £569,039 Security as It Pursues Crystal Bar Design Infringement Case in UK
Yinghe-Controlled Vape Maker SKE Ordered to Post £569,039 Security as It Pursues Crystal Bar Design Infringement Case in UK
The UK High Court has ordered Chinese vape manufacturer Shenzhen SKE Technology to provide £569,039 ($776,000) in security for costs in its design infringement proceedings against Vapepen London and other defendants over its Crystal Bar vape product. The court did not accept the defendants’ main argument that recovering costs from a China-based company would face significant enforcement obstacles, but found that SKE had not sufficiently disclosed its own financial position. The order is procedural and does not determine the underlying infringement claims.
News
Aug.21